Abbott Laboratories (ABT) Stock Research, Analysis & News

Quick Analysis on Abbott Laboratories (ABT) Stock as of November 24, 2017

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Abbott Laboratories (ABT) Stock below)

Abbott Laboratories (ABT) Stock Profile Summary

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. It operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. The Pharmaceutical Products segment offers adult and pediatric pharmaceuticals for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn's disease, dyslipidemia, HIV infection, hypothyroidism, advanced prostate cancer, endometriosis and central precocious puberty, anemia, obesity, epilepsy and bipolar disorder, migraines, secondary hyperparathyroidism, gastroesophageal reflux disease, duodenal and gastric ulcers, and erosive esophagitis, as well as provides anesthesia products and anti-infectives. The Diagnostic Products segment offers immunoassay systems; chemistry systems; assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological, and infectious diseases; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infections agents; genomic-based tests; hematology systems and reagents; and point-of-care diagnostic systems and tests for blood analysis. The Nutritional Products segment provides a line of pediatric and adult nutritional products. The Vascular Products segment offers coronary, endovascular, and vessel closure devices, such as drug-eluting coronary stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, vessel closure devices, and carotid stent systems to treat vascular disease. Additionally, the company provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Abbott Laboratories (ABT) Stock Key Statistics Research and Analysis as of November 24, 2017

Abbott Laboratories (ABT) Stock Competitor Research and Analysis

Merck & Co. Inc. (MRK)Sanofi-Aventis (SNY)
Amgen Inc. (AMGN)Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)GlaxoSmithKline plc (GSK)
Novartis AG (NVS)AstraZeneca PLC (AZN)

Mutual Funds with Abbott Laboratories (ABT) Stock in its top 10 holdings

FundCategoryABT Holding Percentage
Artisan Global Opportunities InvWorld Stock2.9%
Buffalo GrowthLarge Growth2.14%
Diamond Hill Long-Short CLong-Short Equity3.48%
Diamond Hill Large Cap ALarge Value3.64%
Diamond Hill Long-Short ILong-Short Equity3.48%

ETFs with Abbott Laboratories (ABT) Stock in its top 10 holdings

Stock Research on Abbott Laboratories (ABT)

Latest Market News on Abbott Laboratories (ABT)


Click here to find the latest news on Abbott Laboratories (ABT)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Merck & Co. Inc. (MRK)
Sanofi-Aventis (SNY)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Pfizer Inc. (PFE)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Novartis AG (NVS)
AstraZeneca PLC (AZN)